Literature DB >> 23773590

Bacterial meningitis surveillance in the Eastern Mediterranean region, 2005-2010: successes and challenges of a regional network.

Nadia Teleb1, Tamara Pilishvili, Chris Van Beneden, Amani Ghoneim, Khawaja Amjad, Amani Mostafa, Abdul Reza Estighamati, Mohamed Najib Smeo, Abdelaziz Barkia, Mutaz Elkhatib, Abdellatif Mujaly, Hossam Ashmony, Kifah Ahmed Jassim, Rana A Hajjeh.   

Abstract

OBJECTIVE: To describe epidemiology of bacterial meningitis in the World Health Organization Eastern Mediterranean Region countries and assist in introduction of new bacterial vaccines. STUDY
DESIGN: A laboratory-based sentinel surveillance was established in 2004, and up to 10 countries joined the network until 2010. Personnel at participating hospitals and national public health laboratories received training in surveillance and laboratory methods and used standard clinical and laboratory-confirmed case definitions.
RESULTS: Over 22,000 suspected cases of meningitis were reported among children ≤5 years old and >6600 among children >5 years old. In children ≤5 years old, 921 of 13,125 probable cases (7.0%) were culture-confirmed. The most commonly isolated pathogens were S pneumoniae (27% of confirmed cases), N meningitidis (22%), and H influenzae (10%). Among culture-confirmed case-patients with known outcome, case-fatality rate was 7.0% and 12.2% among children ≤5 years old and those >5 years old, respectively. Declining numbers of Haemophilus influenzae type b meningitis cases within 2 years post-Haemophilus influenzae type b conjugate vaccine introduction were observed in Pakistan.
CONCLUSIONS: Bacterial meningitis continues to cause significant morbidity and mortality in the Eastern Mediterranean Region. Surveillance networks for bacterial meningitis ensure that all sites are using standardized methodologies. Surveillance data are useful to monitor impact of various interventions including vaccines, but maintaining data quality requires consistent reporting and regular technical support.
Copyright © 2013. Published by Mosby, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23773590      PMCID: PMC5801662          DOI: 10.1016/j.jpeds.2013.03.027

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Vaccination with Haemophilus influenzae type b conjugate vaccine reduces bacterial meningitis in Morocco.

Authors:  Mohamed Braikat; Abdelaziz Barkia; Naima El Mdaghri; Jeanette J Rainey; Adam L Cohen; Nadia Teleb
Journal:  Vaccine       Date:  2012-02-01       Impact factor: 3.641

Review 2.  The epidemiology of pneumococcal, meningococcal, and Haemophilus disease in the Middle East and North Africa (MENA) region--current status and needs.

Authors:  William P Hausdorff; Rana Hajjeh; Abdulrahman Al-Mazrou; Atef Shibl; Montse Soriano-Gabarro
Journal:  Vaccine       Date:  2006-11-27       Impact factor: 3.641

Review 3.  Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa.

Authors:  Bradford D Gessner
Journal:  Expert Rev Vaccines       Date:  2009-01       Impact factor: 5.217

4.  Progress and future challenges in coordinated surveillance and detection of pneumococcal and Hib disease in developing countries.

Authors:  Orin S Levine; Thomas Cherian; Rana Hajjeh; Maria Deloria Knoll
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

5.  Laboratory-based surveillance for patients with acute meningitis in Sudan, 2004-2005.

Authors:  S Afifi; M S Karsany; M Wasfy; G Pimentel; A Marfin; R Hajjeh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-12       Impact factor: 3.267

6.  Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.

Authors:  F T Cutts; S M A Zaman; G Enwere; S Jaffar; O S Levine; J B Okoko; C Oluwalana; A Vaughan; S K Obaro; A Leach; K P McAdam; E Biney; M Saaka; U Onwuchekwa; F Yallop; N F Pierce; B M Greenwood; R A Adegbola
Journal:  Lancet       Date:  2005 Mar 26-Apr 1       Impact factor: 79.321

Review 7.  Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project.

Authors:  Hope L Johnson; Maria Deloria-Knoll; Orin S Levine; Sonia K Stoszek; Laura Freimanis Hance; Richard Reithinger; Larry R Muenz; Katherine L O'Brien
Journal:  PLoS Med       Date:  2010-10-05       Impact factor: 11.069

8.  Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

Authors:  Tamara Pilishvili; Catherine Lexau; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Arthur Reingold; Ann Thomas; William Schaffner; Allen S Craig; Philip J Smith; Bernard W Beall; Cynthia G Whitney; Matthew R Moore
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

9.  Serogroup W-135 meningococcal disease during the Hajj, 2000.

Authors:  Jairam R Lingappa; Abdullah M Al-Rabeah; Rana Hajjeh; Tajammal Mustafa; Adel Fatani; Tami Al-Bassam; Amira Badukhan; Abdulhafiz Turkistani; Sahar Makki; Nassen Al-Hamdan; Mohamed Al-Jeffri; Yaqoub Al Mazrou; Bradley A Perkins; Tonja Popovic; Leonard W Mayer; Nancy E Rosenstein
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

  9 in total
  5 in total

1.  Progress towards demonstrating the impact of Haemophilus influenzae type b conjugate vaccines globally.

Authors:  Rana Hajjeh; Kim Mulholland; Anne Schuchat; Mathuram Santosham
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

2.  Epidemiology and Risk Factors Associated with Developing Bacterial Meningitis among Children in Gaza Strip.

Authors:  Abdel Moat Al Jarousha; Ahmed Al Afifi
Journal:  Iran J Public Health       Date:  2014-09       Impact factor: 1.429

Review 3.  Acute bacterial meningitis in Iran: Systematic review and meta-analysis.

Authors:  Hamidreza Houri; Ali Pormohammad; Seyed Mohammad Riahi; Mohammad Javad Nasiri; Fatemeh Fallah; Hossein Dabiri; Ramin Pouriran
Journal:  PLoS One       Date:  2017-02-07       Impact factor: 3.240

4.  Global etiology of bacterial meningitis: A systematic review and meta-analysis.

Authors:  Anouk M Oordt-Speets; Renee Bolijn; Rosa C van Hoorn; Amit Bhavsar; Moe H Kyaw
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

5.  High-throughput sequencing of 16S rDNA amplicons characterizes bacterial composition in cerebrospinal fluid samples from patients with purulent meningitis.

Authors:  Aicui Liu; Chao Wang; Zhijuan Liang; Zhi-Wei Zhou; Lin Wang; Qiaoli Ma; Guowei Wang; Shu-Feng Zhou; Zhenhai Wang
Journal:  Drug Des Devel Ther       Date:  2015-08-07       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.